Proceeding contribution from Jack Straw (Labour) in the House of Commons on Thursday, 1 February 2007. It occurred during Business statement on Business of the House.
Business of the House
Of course I understand the hon. Lady’s concern. Health questions will take place next Tuesday, and she has not missed the deadline, so I suggest that she table a question. There is, I think, cross-party agreement that the NICE arrangement for independent assessment of new drug treatments is sensible, and better than the alternative. Whoever is in government, there are critical and difficult questions about whether to approve drugs and make them generally available. That is the reality, but I am aware that some individuals at the margin are disadvantaged and are in a difficult position.
Secondary information
- Type
- Proceeding contribution
- Reference
- 456 c369
- Session
- 2006-07
- Chamber / Committee
- House of Commons chamber
- Subjects
- NHS Medical treatments Prescription drugs National Institute for Health and Care Excellence
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-15 12:41:38 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1208684/answer
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1208684/answer
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1208684/answer